Alpha 2.0
Login Register
» Journals » Rheumatol Ther

Rheumatology and Therapy

Rheumatology and Therapy is a scientific journal, published since 2014 in English. The journal's country of origin is United Kingdom and its primary focus area is rehabilitation medicine.
Details
Abbr. Rheumatol Ther
Start 2014
End Continuing
Frequency Two issues a year, 2015-
p-ISSN 2198-6576
e-ISSN 2198-6584
Country United Kingdom
Language English
Specialty Rehabilitation Medicine
Metrics
h-index / Ranks: 9569 35
SJR / Ranks: 3364 1071
CiteScore / Ranks: 4778 5.20
JIF / Ranks: 2461 3.8
Recent Articles
11.
Real-World-Evidence of Digital Health Applications (DiGAs) in Rheumatology: Insights from the DiGAReal Registry
Albrecht A, Taubmann J, Minopoulou I, Hatscher L, Kleinert S, Muhlensiepen F, et al.
Rheumatol Ther . 2025 Jan; PMID: 39836353
Introduction: Prescribable digital health applications (DiGAs) present scalable solutions to improve patient self-management in rheumatology, however real-world evidence is scarce. Therefore, we aimed to assess the effectiveness, usage, and usability...
12.
Letter to the Editor Regarding "Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance"
Goyal M
Rheumatol Ther . 2025 Jan; PMID: 39833650
No abstract available.
13.
A Response to: Letter to the Editor Regarding "Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance"
Batko B, Rivas J
Rheumatol Ther . 2025 Jan; PMID: 39833649
No abstract available.
14.
Letter to the Editor Regarding: "Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry"
Liu Z, Tian M, Duan L
Rheumatol Ther . 2025 Jan; PMID: 39826083
No abstract available.
15.
Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease
Bettacchioli E, Cornec D, Gardien P, Queneherve L, Guellec D, Tison A, et al.
Rheumatol Ther . 2025 Jan; PMID: 39808243
Introduction: Celiac disease (CD) affects the small intestine, leading to a progressive disappearance of intestinal villi, and can be found in association with several other autoimmune and inflammatory conditions. The...
16.
Association Between Diagnostic Delay and Economic and Clinical Burden in Axial Spondyloarthritis: A Multicentre Retrospective Observational Study
Berbel-Arcobe L, Aparicio M, Calvet J, Arevalo M, Nack A, Juanola X, et al.
Rheumatol Ther . 2025 Jan; PMID: 39804521
Introduction: Axial spondyloarthritis (axSpA) is a chronic inflammatory condition associated with considerable pain and impaired health-related quality of life (HRQoL) for affected patients. Despite the documented increase in healthcare resource...
17.
Real-World Prevalence, Incidence and Management of Systemic Lupus Erythematosus in Germany: A Retrospective Claims Data Analysis
Alexander T, Sewerin P, Strangfeld A, Schulte M, Borchert J, Garcia T, et al.
Rheumatol Ther . 2025 Jan; PMID: 39776056
Introduction: This study evaluated the prevalence and incidence of systemic lupus erythematosus (SLE) in Germany and explored real-world data on sequence of therapy (SOT; sequence of drugs as prescribed in...
18.
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis
Youssef P, Ciciriello S, Tahir T, Leadbetter J, Butcher B, Calao M, et al.
Rheumatol Ther . 2025 Jan; 12(1):173-202. PMID: 39757285
Introduction: This study sought to describe treatment patterns, persistence, and effectiveness of upadacitinib (UPA) alone and compared to other Janus kinase inhibitors (JAKis) or tumor necrosis factor inhibitors (TNFis) in...
19.
Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients with Knee Osteoarthritis: A Multicenter, Observational Extension Trial
Swearingen C, Tambiah J, Simsek I, Ghandehari H, Kennedy S, Yazici Y
Rheumatol Ther . 2025 Jan; 12(1):157-171. PMID: 39755925
Introduction: Lorecivivint (LOR), a CDC-like kinase/dual-specificity tyrosine kinase (CLK/DYRK) inhibitor thought to modulate inflammatory and Wnt pathways, is being developed as a potential intra-articular knee osteoarthritis (OA) treatment. The objective...
20.
Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
Oommen P, Kallinich T, Rech J, Blank N, Weber-Arden J, Kuemmerle-Deschner J
Rheumatol Ther . 2024 Dec; 12(1):137-155. PMID: 39724475
Introduction: Interim analysis of the long-term safety and effectiveness of canakinumab, at a patient level, in the mevalonate kinase deficiency/hyperimmunoglobulin-D syndrome (MKD/HIDS) cohort of the RELIANCE registry. Methods: From June...